MedPath

Coca-Cola Faces Antitrust Scrutiny in COMESA and Kenya

9 months ago1 min read

Key Insights

  • Coca-Cola is under investigation by the COMESA Competition Commission for potential antitrust violations related to restrictive distribution agreements.

  • Kenya's Competition Authority is also scrutinizing Coca-Cola for similar antitrust breaches related to distribution practices.

  • Espar settled for millions to avoid claims of colluding to fix vehicle parking heater prices, while Sika received conditional Phase II clearance in Peru.

Coca-Cola is facing antitrust scrutiny from the Common Market for Eastern and Southern Africa (COMESA) Competition Commission and the Competition Authority of Kenya for allegedly engaging in restrictive distribution agreements. These agreements are suspected of violating antitrust regulations within the region.
The investigations focus on whether Coca-Cola's distribution practices unfairly limit competition and harm other businesses. The specific details of the alleged restrictive agreements have not been fully disclosed, but regulators are examining the terms and conditions under which Coca-Cola products are distributed to retailers and other outlets.
In related news, Espar reached a multi-million dollar settlement to resolve claims of colluding to fix the price of vehicle parking heaters. Separately, Sika, a specialty chemicals company, received a rare Phase II conditional clearance in Peru, indicating regulatory approval with specific conditions attached.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.